SPEX compositions and methods of use

Details for Australian Patent Application No. 2004234532 (hide)

Owner The Scripps Research Institute Novartis AG

Inventors Wilkinson, Beverley; Kaye, Jonathan

Agent Davies Collison Cave

Pub. Number AU-A-2004234532

PCT Pub. Number WO2004/096976

Priority 60/467,206 30.04.03 US

Filing date 29 April 2004

Wipo publication date 11 November 2004

International Classifications

C07K 014/47 Peptides having more than 20 amino acids

Event Publications

3 November 2005 PCT application entered the National Phase

  PCT publication WO2004/096976 Priority application(s): WO2004/096976

11 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004234535-Core/shell nanoparticles suitable for (F)RET-assays

2004234531-Quickly disintegrating pigment concentrate